106 related articles for article (PubMed ID: 27042764)
21. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
22. Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.
Sherif MF; Ismail IM; Ata SMS
Ann Diagn Pathol; 2020 Dec; 49():151621. PubMed ID: 32949893
[TBL] [Abstract][Full Text] [Related]
23. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of ezrin/radixin/moesin (ERM) and ERM-associated adhesion molecules in the blastocyst and uterus suggests their functions during implantation.
Matsumoto H; Daikoku T; Wang H; Sato E; Dey SK
Biol Reprod; 2004 Mar; 70(3):729-36. PubMed ID: 14613898
[TBL] [Abstract][Full Text] [Related]
25. Foxj1 is required for apical localization of ezrin in airway epithelial cells.
Huang T; You Y; Spoor MS; Richer EJ; Kudva VV; Paige RC; Seiler MP; Liebler JM; Zabner J; Plopper CG; Brody SL
J Cell Sci; 2003 Dec; 116(Pt 24):4935-45. PubMed ID: 14625387
[TBL] [Abstract][Full Text] [Related]
26. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
[TBL] [Abstract][Full Text] [Related]
27. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
28. Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes.
Melendez-Vasquez CV; Rios JC; Zanazzi G; Lambert S; Bretscher A; Salzer JL
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1235-40. PubMed ID: 11158623
[TBL] [Abstract][Full Text] [Related]
29. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
30. Ezrin expression as a prognostic marker in colorectal adenocarcinoma.
Patara M; Santos EM; Coudry Rde A; Soares FA; Ferreira FO; Rossi BM
Pathol Oncol Res; 2011 Dec; 17(4):827-33. PubMed ID: 21465252
[TBL] [Abstract][Full Text] [Related]
31. Expression of ezrin radixin moesin proteins in the adult subventricular zone and the rostral migratory stream.
Persson A; Lindwall C; Curtis MA; Kuhn HG
Neuroscience; 2010 May; 167(2):312-22. PubMed ID: 20109539
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of ezrin in esophageal squamous cell carcinoma.
Zeng H; Xu L; Xiao D; Zhang H; Wu X; Zheng R; Li Q; Niu Y; Shen Z; Li E
J Histochem Cytochem; 2006 Aug; 54(8):889-96. PubMed ID: 16585385
[TBL] [Abstract][Full Text] [Related]
33. Viscum album agglutinin-I (VAA-I) increases cell surface expression of cytoskeletal proteins in apoptotic human neutrophils: moesin and ezrin are two novel targets of VAA-I.
Simon MM; Simard JC; Girard D
Hum Exp Toxicol; 2013 Oct; 32(10):1097-106. PubMed ID: 23263853
[TBL] [Abstract][Full Text] [Related]
34. Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence.
Cui G; Xu G; Zhu L; Pang Z; Zheng W; Li Z; Yuan A
Oncotarget; 2017 Jul; 8(28):45311-45322. PubMed ID: 28484082
[TBL] [Abstract][Full Text] [Related]
35. Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
Miyaji K; Shahrizaila N; Umapathi T; Chan YC; Hirata K; Yuki N
Hum Immunol; 2014 Nov; 75(11):1089-91. PubMed ID: 25286001
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical Study of Ezrin Expression in Colorectal Carcinoma: A Comparative Study between Objective Method and Digital Quantitative Assessment.
Ayad EE; Kamal Eldin YO; El-Hindawi AA; Abdelmagid MS; Elmeligy HA
Asian Pac J Cancer Prev; 2020 Apr; 21(4):967-974. PubMed ID: 32334457
[TBL] [Abstract][Full Text] [Related]
37. Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes.
Barreiro O; Yanez-Mo M; Serrador JM; Montoya MC; Vicente-Manzanares M; Tejedor R; Furthmayr H; Sanchez-Madrid F
J Cell Biol; 2002 Jun; 157(7):1233-45. PubMed ID: 12082081
[TBL] [Abstract][Full Text] [Related]
38. [The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma].
Duan GJ; Yan XC; Bian XW; Li J; Chen X
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):518-22. PubMed ID: 15634446
[TBL] [Abstract][Full Text] [Related]
39. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I
J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285
[TBL] [Abstract][Full Text] [Related]
40. Novel insights of the gastric gland organization revealed by chief cell specific expression of moesin.
Zhu L; Hatakeyama J; Zhang B; Makdisi J; Ender C; Forte JG
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G185-95. PubMed ID: 19074636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
